Tonghua Dongbao Pharmaceutical Co., Ltd.SSE: 600867

Announcement on Implementation Results of Repurchasing Shares through Call Auction and Share Changes

Apr 11, 2026 · Issued by Tonghua Dongbao Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Apr 11, 2026

On 6ix: 6ix.com/news/announcement-on-implementation-results-of-repurchasing-shares-through-call-auction-and-share-changes

Announcement on Implementation Results of Repurchasing Shares through Call Auction and Share Changes

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Tonghua Dongbao Pharmaceutical Co., Ltd. on 6ix

Earlier from Tonghua Dongbao Pharmaceutical

Announcement on Progress in Repurchasing Shares through Call AuctionApr 2
Rectification Report on Decision on Administrative Supervision Measures from Jilin Office of China Securities Regulatory CommissionFeb 11
Announcement on Receiving Decision on Administrative Supervision Measures from Jilin Securities Regulatory BureauJan 31
Announcement on Expected Increase in Performance for 2025Jan 27
Announcement on Appointment of Senior Management MembersJan 16

Later from Tonghua Dongbao Pharmaceutical

Announcement on Implementation of Daily Related Transactions in 2025 and Estimated Daily Related Party Transactions in 2026Apr 20
Announcement on Resolutions of the 25th Meeting of the 11th Board of DirectorsApr 29
Announcement on Convening the 2025 Annual and Q1 2026 Performance Briefing and Attending the 2026 Online Collective Reception Day for Investors of Listed Companies in JilinMay 12
Announcement on Resolutions of the 2025 Annual General MeetingMay 13
Announcement on Obtaining Overseas Drug Registration Certificates for Liraglutide InjectionMay 26

All Tonghua Dongbao Pharmaceutical news releases

Follow Tonghua Dongbao Pharmaceutical into a list and get an email when it puts out news.

Follow Tonghua Dongbao Pharmaceutical